awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38100203-BDF5B9E7-63B2-4F7B-8274-20F6B8DC28EE
Q38100203-BDF5B9E7-63B2-4F7B-8274-20F6B8DC28EE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38100203-BDF5B9E7-63B2-4F7B-8274-20F6B8DC28EE
Cyclin-dependent kinase inhibitors closer to market launch?
P2860
Q38100203-BDF5B9E7-63B2-4F7B-8274-20F6B8DC28EE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38100203-BDF5B9E7-63B2-4F7B-8274-20F6B8DC28EE
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
56b8679b8faaa38516ce30a48a7d0c3991ad8670
P2860
Antiproliferative activity of olomoucine II, a novel 2,6,9-trisubstituted purine cyclin-dependent kinase inhibitor.